Global Product Manager for Stem Cell and 3D Cell Culture
Global Product Manager for Stem Cell and 3D Cell Culture
Consultant, Associate Chair of Academic Affairs and Faculty development, Dept. of Quantitative Health Sciences, Associate Professor, Biomedical Informatics, Mayo Clinic College of Medicine
Manager Product Development, Life Sciences, Thermo Fisher Scientific
Assistant Professor, Family Medicine and Community Health; Director, Center for Equity in Research, Duke Clinical Translational Science Institute (CTSI);
Product Manager, CellStream, Luminex Corporation
Chief Scientific Officer, QIAGEN Digital Insights
Head of COSMIC, Wellcome Sanger Institute, Cambridge, UK
Product Manager, Microcapillary Flow Cytometry, Luminex Corporation
Product Manager, Image Flow Cytometry, Luminex Corporation
Senior Manager of R&D, Miltenyi Biotec
Global Product Director of Oncology, QIAGEN Digital Insights
Associate Professor of Biology, Principal Investigator, NIH Bridges-to-the-Doctorate Program, North Carolina A and T State University
Program Manager, Office of Health Equity, Duke Cancer Institute; Adjunct Associate Professor, University of North Carolina at Chapel Hill, School of Nursing
Assistant Professor, Department of Urology, Northwestern Medicine - Feinberg School of Medicine; Affiliate Member of Center for Global Health and Center for Community Health
Professor of Computational Biology and Bioinformatics, Chair of the Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
Associate Professor/Chair of Department of Biology, North Carolina A&T State University
Global Product Manager, QIAGEN Digital Insight​s
Assistant Professor of Oncology and Cancer Research Immunology, Johns Hopkins University School of Medicine Member, Bloomberg-Kimmel Institute for Cancer Immunotherapy
Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 9th Annual Event in the Cancer Research & Oncology Week Virtual Event Series! This two-day event will take place on October 6th and 7th, 2021 and will focus on advancements in the prevention, diagnosis, and treatment of different cancer types.
Cancer research has made major advancements in diagnosis, treatments, and the basic understanding of the disease itself. Each year we see progress in immunotherapy, treatments involving nanotechnology, advances in targeted and personalized therapeutics and drug development, and a decrease in mortality rates due to a strong focus on learning more about the origination of the disease.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 Cancer Research and Oncology Virtual Event. Submission is free. Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global community with a high degree of interaction through live-streaming video and chat sessions.
Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 35 credits.
Use #LRcancer to follow the conversation!
Sino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers ...
See moreAt Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic ...
See moreEnvigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia, and other life science organizations. As the largest organization that is solely dedicated to providing research models and related ...
See moreNanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications ...
See moreAtlas Antibodies is a Swedish biotechnology company driving leading research worldwide through providing affinity-purified monoclonal and polyclonal antibodies, and control antigens. Our product portfolio extensively covers human proteins in cells, tissues, and organs. With our ...
See moreOur purpose is to solve the toughest problems in life science by collaborating with the global scientific community - and through that, we aim to accelerate access to better health for people everywhere.
Asuragen is a molecular diagnostic product company changing the way patients are treated in genetics and oncology. Asuragen's diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using broadly installed instrument platforms. They are simple ...
See moreFor over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell ...
See morePerkinElmer is working closely with laboratories around the world to deliver the nucleic acid isolation, automation, real-time PCR, antibody testing, and NGS library preparation solutions they need to rapidly respond to the SARS-CoV-2 challenges both today and tomorrow. To ...
See moreAs the scientific community races to solve this evolving global health crisis, Twist Bioscience is proud to carry on as an active partner for all of your research needs. Twist's unique silicon-based DNA writing platform allows for the rapid development of NGS panels for viral ...
See moreJonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...
See moreKeith L. Knutson, Ph.D., is a consultant in the Department of Immunology, Mayo Clinic in Florida, where he also serves as director of the Discovery and Translation Lab's Cancer Research Program. Dr. Knutson joined the staff of Mayo Clinic in 2005 and holds the academic rank of ...
See moreDr. Rajan T. Gupta, MD, is an Assistant Professor of Radiology in the Division of Abdominal Imaging at Duke University Medical Center, as well as the Director of the Abdominal Imaging Fellowship Program and a Faculty physician in the Duke Cancer Institute. Since 2009, he has been ...
See moreDr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...
See more